Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy: Difference between revisions
m (]) |
([[) |
||
Line 84: | Line 84: | ||
[[Status epilepticus]] | [[Status epilepticus]] | ||
[[West's syndrome]] | |||
[[Category:Disease]] | [[Category:Disease]] |
Revision as of 18:42, 3 August 2015
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO[2] states 50-70 millions persons[3] suffers epilepsy[4]
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance wih AED[5]
Medicines | ||||
type | ,,, | ,,,, | ||
INN | Generic | slow release | ||
carbamazepine | normal | xr | ||
lamotrigine | normal | xr | ||
levetiracetam | normal | xr | ||
oxcarbazepine | ... | xr | ||
phenitoin | ... | xr | ||
valproate | xr | |||
topiramate | xr | |||
AED |
Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline
ILAE Classification
See also
A new perspective for Epileptic Disorders
Links
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
References: |
|